Firvanq price?

See the DrugPatentWatch profile for Firvanq

How much does Firvanq cost?

Firvanq is a medication used to prevent delayed onset of hemolysis in adult patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency when receiving malaria treatment with atovaquone or tafenoquine. The price of Firvanq can vary depending on the location, pharmacy, and insurance coverage.

According to DrugPatentWatch.com, the list price of Firvanq in the United States is around $5,300 per 200 mg tablet [1].

Does insurance coverage affect the cost of Firvanq?

The cost of Firvanq may be significantly reduced for patients with insurance coverage. Medicare, Medicaid, and private insurance plans may cover a portion of the medication's cost, depending on the specific plan and patient's out-of-pocket expenses.

Can patients get Firvanq on a budget?

Some patients and advocacy groups promote budget-friendly alternatives or patient assistance programs to help make Firvanq more affordable. However, these alternatives may have varying levels of effectiveness and access limitations.

When will exclusivity expire for Firvanq?

Firvanq is a relatively new medication, and its exclusivity rights are expected to expire in 2027, as reported by DrugPatentWatch.com [2]. After that, generic versions of the medication may become available, potentially reducing the cost of treatment.

What side effects are patients asking about?

Firvanq has been associated with several side effects, including headache, dizziness, nausea, and vomiting. Patients should consult their healthcare provider about potential side effects and any concerns they may have.

Sources:

[1] DrugPatentWatch.com - Firvanq price
[2] DrugPatentWatch.com - Firvanq exclusivity expiration date